<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36936908</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>21</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients.</ArticleTitle><Pagination><StartPage>1147526</StartPage><MedlinePgn>1147526</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1147526</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1147526</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Pathologic inflammation is a major driver of kidney damage in lupus nephritis (LN), but the immune mechanisms of disease progression and risk factors for end organ damage are poorly understood.</AbstractText><AbstractText Label="METHODS">To characterize molecular profiles through the development of LN, we carried out gene expression analysis of microdissected kidneys from lupus-prone NZM2328 mice. We examined male mice and the congenic NZM2328.R27 strain as a means to define mechanisms associated with resistance to chronic nephritis. Gene expression profiles in lupus mice were compared with those in human LN.</AbstractText><AbstractText Label="RESULTS">NZM2328 mice exhibited progress from acute to transitional and then to chronic glomerulonephritis (GN). Each stage manifested a unique molecular profile. Neither male mice nor R27 mice progressed past the acute GN stage, with the former exhibiting minimal immune infiltration and the latter enrichment of immunoregulatory gene signatures in conjunction with robust kidney tubule cell profiles indicative of resistance to cellular damage. The gene expression profiles of human LN were similar to those noted in the NZM2328 mouse suggesting comparable stages of LN progression.</AbstractText><AbstractText Label="CONCLUSIONS">Overall, this work provides a comprehensive examination of the immune processes involved in progression of murine LN and thus contributes to our understanding of the risk factors for end-stage renal disease. In addition, this work presents a foundation for improved classification of LN and illustrates the applicability of murine models to identify the stages of human disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Daamen, Wang, Bachali, Shen, Kingsmore, Robl, Grammer, Fu and Lipsky.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Daamen</LastName><ForeName>Andrea R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Hongyang</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Immunity, Inflammation, and Regenerative Medicine, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bachali</LastName><ForeName>Prathyusha</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shen</LastName><ForeName>Nan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Shanghai Institute of Rheumatology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kingsmore</LastName><ForeName>Kathryn M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robl</LastName><ForeName>Robert D</ForeName><Initials>RD</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grammer</LastName><ForeName>Amrie C</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fu</LastName><ForeName>Shu Man</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Center for Immunity, Inflammation, and Regenerative Medicine, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lipsky</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><AffiliationInfo><Affiliation>AMPEL BioSolutions LLC, Charlottesville, VA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AR047988</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI148231</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>03</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007668" MajorTopicYN="N">Kidney</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008181" MajorTopicYN="Y">Lupus Nephritis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005921" MajorTopicYN="Y">Glomerulonephritis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002908" MajorTopicYN="N">Chronic Disease</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">bioinformatics</Keyword><Keyword MajorTopicYN="N">lupus</Keyword><Keyword MajorTopicYN="N">mouse models</Keyword><Keyword MajorTopicYN="N">nephritis</Keyword><Keyword MajorTopicYN="N">transcriptomics</Keyword><Keyword MajorTopicYN="N">translational</Keyword></KeywordList><CoiStatement>Authors AD, PB, KK, RR, AG, and PL were employed by AMPEL BioSolutions LLC. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>20</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36936908</ArticleId><ArticleId IdType="pmc">PMC10016352</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1147526</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Davidson A. What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol (2016) 12:143&#x2013;53. doi:&#xa0;10.1038/nrrheum.2015.159</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2015.159</ArticleId><ArticleId IdType="pmc">PMC4820834</ArticleId><ArticleId IdType="pubmed">26581344</ArticleId></ArticleIdList></Reference><Reference><Citation>Maria NI, Davidson A. Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy. Nat Rev Rheumatol (2020) 16:255&#x2013;67. doi:&#xa0;10.1038/s41584-020-0401-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0401-9</ArticleId><ArticleId IdType="pubmed">32203285</ArticleId></ArticleIdList></Reference><Reference><Citation>Mimura I, Nangaku M. The suffocating kidney: Tubulointerstitial hypoxia in end-stage renal disease. Nat Rev Nephrol (2010) 6:667&#x2013;78. doi:&#xa0;10.1038/nrneph.2010.124</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2010.124</ArticleId><ArticleId IdType="pubmed">20877304</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Fueyo A, Bradley SJ, Klatzmann D, Tsokos GC. T Cells and autoimmune kidney disease. Nat Rev Nephrol (2017) 13:329&#x2013;43. doi:&#xa0;10.1038/nrneph.2017.34</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2017.34</ArticleId><ArticleId IdType="pubmed">28287110</ArticleId></ArticleIdList></Reference><Reference><Citation>Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol (2006) 17:17&#x2013;25. doi:&#xa0;10.1681/ASN.2005070757</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2005070757</ArticleId><ArticleId IdType="pubmed">16291837</ArticleId></ArticleIdList></Reference><Reference><Citation>Leatherwood C, Speyer CB, Feldman CH, D&#x2019;Silva K, G&#xf3;mez-Puerta JA, Hoover PJ, et al. . Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies. Semin Arthritis Rheum (2019) 49:396&#x2013;404. doi:&#xa0;10.1016/j.semarthrit.2019.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2019.06.002</ArticleId><ArticleId IdType="pmc">PMC6888990</ArticleId><ArticleId IdType="pubmed">31277928</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu B-C, Tang T-T, Lv L-L, Lan H-Y. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int (2018) 93:568&#x2013;79. doi:&#xa0;10.1016/j.kint.2017.09.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2017.09.033</ArticleId><ArticleId IdType="pubmed">29361307</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz MM, Lan SP, Bernstein J, Hill GS, Holley K, Lewis EJ. Irreproducibility of the activity and chronicity indices limits their utility in the management of lupus nephritis. lupus nephritis collaborative study group. Am J Kidney Dis Off J Natl Kidney Found (1993) 21:374&#x2013;7. doi:&#xa0;10.1016/s0272-6386(12)80263-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0272-6386(12)80263-0</ArticleId><ArticleId IdType="pubmed">8465815</ArticleId></ArticleIdList></Reference><Reference><Citation>Mubarak M, Nasri H. ISN/RPS 2003 classification of lupus nephritis: time to take a look on the achievements and limitations of the schema. J Nephropathol (2014) 3:87&#x2013;90. doi:&#xa0;10.12860/jnp.2014.17</Citation><ArticleIdList><ArticleId IdType="doi">10.12860/jnp.2014.17</ArticleId><ArticleId IdType="pmc">PMC4119328</ArticleId><ArticleId IdType="pubmed">25093155</ArticleId></ArticleIdList></Reference><Reference><Citation>Almaani S, Prokopec SD, Zhang J, Yu L, Avila-Casado C, Wither J, et al. . Rethinking lupus nephritis classification on a molecular level. J Clin Med (2019) 8. doi:&#xa0;10.3390/jcm8101524</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8101524</ArticleId><ArticleId IdType="pmc">PMC6832959</ArticleId><ArticleId IdType="pubmed">31547518</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters ST, Fu SM, Gaskin F, Deshmukh US, Sung SS, Kannapell CC, et al. . NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. Clin Immunol (2001) 100:372&#x2013;83. doi:&#xa0;10.1006/clim.2001.5079</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clim.2001.5079</ArticleId><ArticleId IdType="pubmed">11513551</ArticleId></ArticleIdList></Reference><Reference><Citation>Waters ST, McDuffie M, Bagavant H, Deshmukh US, Gaskin F, Jiang C, et al. . Breaking tolerance to double stranded DNA, nucleosome, and other nuclear antigens is not required for the pathogenesis of lupus glomerulonephritis. J Exp Med (2004) 199:255&#x2013;64. doi:&#xa0;10.1084/jem.20031519</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20031519</ArticleId><ArticleId IdType="pmc">PMC2211766</ArticleId><ArticleId IdType="pubmed">14718514</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge Y, Jiang C, Sung SSJ, Bagavant H, Dai C, Wang H, et al. . Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex-mediated acute lupus glomerulonephritis. J Exp Med (2013) 210:2387&#x2013;401. doi:&#xa0;10.1084/jem.20130731</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20130731</ArticleId><ArticleId IdType="pmc">PMC3804943</ArticleId><ArticleId IdType="pubmed">24101379</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagavant H, Deshmukh US, Wang H, Ly T, Fu SM. Role for nephritogenic T cells in lupus glomerulonephritis: Progression to renal failure is accompanied by T cell activation and expansion in regional lymph nodes. J Immunol (2006) 177:8258&#x2013;65. doi:&#xa0;10.4049/jimmunol.177.11.8258</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.11.8258</ArticleId><ArticleId IdType="pubmed">17114504</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu SM, Wang H, Dai C, Sung S-SJ, Gaskin F. Pathogenesis of proliferative lupus nephritis from a historical and personal perspective. Clin Immunol (2017) 185:51&#x2013;8. doi:&#xa0;10.1016/j.clim.2016.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.07.024</ArticleId><ArticleId IdType="pmc">PMC5332347</ArticleId><ArticleId IdType="pubmed">27591148</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson KS, Huang J-F, Zhu J, D&#x2019;Agati V, Liu X, Miller N, et al. . Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. J Clin Invest (2004) 113:1722&#x2013;33. doi:&#xa0;10.1172/JCI19139</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI19139</ArticleId><ArticleId IdType="pmc">PMC420500</ArticleId><ArticleId IdType="pubmed">15199407</ArticleId></ArticleIdList></Reference><Reference><Citation>Espina V, Wulfkuhle JD, Calvert VS, VanMeter A, Zhou W, Coukos G, et al. . Laser-capture microdissection. Nat Protoc (2006) 1:586&#x2013;603. doi:&#xa0;10.1038/nprot.2006.85</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.85</ArticleId><ArticleId IdType="pubmed">17406286</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinf (2013) 14:7. doi:&#xa0;10.1186/1471-2105-14-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-7</ArticleId><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Bult CJ, Blake JA, Smith CL, Kadin JA, Richardson JE. Mouse genome database (MGD) 2019. Nucleic Acids Res (2019) 47:D801&#x2013;6. doi:&#xa0;10.1093/nar/gky1056</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1056</ArticleId><ArticleId IdType="pmc">PMC6323923</ArticleId><ArticleId IdType="pubmed">30407599</ArticleId></ArticleIdList></Reference><Reference><Citation>Heng TSP, Painter MW, Elpek K, Lukacs-Kornek V, Mauermann N, Turley SJ, et al. . The immunological genome project: networks of gene expression in immune cells. Nat Immunol (2008) 9:1091&#x2013;4. doi:&#xa0;10.1038/ni1008-1091</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1008-1091</ArticleId><ArticleId IdType="pubmed">18800157</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingsmore KM, Bachali P, Catalina MD, Daamen AR, Heuer SE, Robl RD, et al. . Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus. Sci Rep (2021) 11:14789. doi:&#xa0;10.1038/s41598-021-93034-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93034-w</ArticleId><ArticleId IdType="pmc">PMC8292402</ArticleId><ArticleId IdType="pubmed">34285256</ArticleId></ArticleIdList></Reference><Reference><Citation>Kr&#xe4;mer A, Green J, Pollard JJ, Tugendreich S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics (2014) 30:523&#x2013;30. doi:&#xa0;10.1093/bioinformatics/btt703</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt703</ArticleId><ArticleId IdType="pmc">PMC3928520</ArticleId><ArticleId IdType="pubmed">24336805</ArticleId></ArticleIdList></Reference><Reference><Citation>Song WM, Zhang B. Multiscale embedded gene Co-expression network analysis. PloS Comput Biol (2015) 11. doi:&#xa0;10.1371/journal.pcbi.1004574</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004574</ArticleId><ArticleId IdType="pmc">PMC4664553</ArticleId><ArticleId IdType="pubmed">26618778</ArticleId></ArticleIdList></Reference><Reference><Citation>The gene ontology resource: enriching a GOld mine. Nucleic Acids Res (2021) 49:D325&#x2013;34. doi:&#xa0;10.1093/nar/gkaa1113</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkaa1113</ArticleId><ArticleId IdType="pmc">PMC7779012</ArticleId><ArticleId IdType="pubmed">33290552</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: An r package for weighted correlation network analysis. BMC Bioinf (2008) 9. doi:&#xa0;10.1186/1471-2105-9-559</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics (2016) 32:2847&#x2013;9. doi:&#xa0;10.1093/bioinformatics/btw313</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Markowitz GS, D&#x2019;Agati VD. The ISN/RPS 2003 classification of lupus nephritis: An assessment at 3 years. Kidney Int (2007) 71:491&#x2013;5. doi:&#xa0;10.1038/sj.ki.5002118</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002118</ArticleId><ArticleId IdType="pubmed">17264872</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannik M, Merrill CE, Stamps LD, Wener MH. Multiple autoantibodies form the glomerular immune deposits in patients with systemic lupus erythematosus. J Rheumatol (2003) 30:1495&#x2013;504.</Citation><ArticleIdList><ArticleId IdType="pubmed">12858447</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds J, Norgan VA, Bhambra U, Smith J, Cook HT, Pusey CD. Anti-CD8 monoclonal antibody therapy is effective in the prevention and treatment of experimental autoimmune glomerulonephritis. J Am Soc Nephrol (2002) 13:359&#x2013;69. doi:&#xa0;10.1681/ASN.V132359</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.V132359</ArticleId><ArticleId IdType="pubmed">11805163</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen A, Lee K, Guan T, He JC, Schlondorff D. Role of CD8+ T cells in crescentic glomerulonephritis. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc Eur Ren Assoc (2020) 35:564&#x2013;72. doi:&#xa0;10.1093/ndt/gfz043</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfz043</ArticleId><ArticleId IdType="pmc">PMC7139212</ArticleId><ArticleId IdType="pubmed">30879039</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzi L, Merville P, Demini&#xe8;re C, Moreau J-F, Combe C, Pellegrin J-L, et al. . Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. Arthritis Rheum (2007) 56:2362&#x2013;70. doi:&#xa0;10.1002/art.22654</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.22654</ArticleId><ArticleId IdType="pubmed">17599764</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HJ, Wang X, Radfar S, Sproule TJ, Roopenian DC, Cantor H. CD8+ T regulatory cells express the Ly49 class I MHC receptor and are defective in autoimmune prone B6-yaa mice. Proc Natl Acad Sci U.S.A. (2011) 108:2010&#x2013;5. doi:&#xa0;10.1073/pnas.1018974108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1018974108</ArticleId><ArticleId IdType="pmc">PMC3033298</ArticleId><ArticleId IdType="pubmed">21233417</ArticleId></ArticleIdList></Reference><Reference><Citation>Arazi A, Rao DA, Berthier CC, Davidson A, Liu Y, Hoover PJ, et al. . The immune cell landscape in kidneys of patients with lupus nephritis. Nat Immunol (2019) 20:902&#x2013;14. doi:&#xa0;10.1038/s41590-019-0398-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0398-x</ArticleId><ArticleId IdType="pmc">PMC6726437</ArticleId><ArticleId IdType="pubmed">31209404</ArticleId></ArticleIdList></Reference><Reference><Citation>Toro-Dom&#xed;nguez D, Martorell-Marug&#xe1;n J, Goldman D, Petri M, Carmona-S&#xe1;ez P, Alarc&#xf3;n-Riquelme ME. Stratification of systemic lupus erythematosus patients into three groups of disease activity progression according to longitudinal gene expression. Arthritis Rheumatol (2018) 70:2025&#x2013;35. doi:&#xa0;10.1002/art.40653</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40653</ArticleId><ArticleId IdType="pmc">PMC8326877</ArticleId><ArticleId IdType="pubmed">29938934</ArticleId></ArticleIdList></Reference><Reference><Citation>Der E, Suryawanshi H, Morozov P, Kustagi M, Goilav B, Ranabathou S, et al. . Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways. Nat Immunol (2019) 20:915&#x2013;27. doi:&#xa0;10.1038/s41590-019-0386-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-019-0386-1</ArticleId><ArticleId IdType="pmc">PMC6584054</ArticleId><ArticleId IdType="pubmed">31110316</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung SJ, Ge Y, Dai C, Wang H, Fu SM, Sharma R, et al. . Dependence of glomerulonephritis induction on novel intraglomerular alternatively activated bone marrow&#x2013;derived macrophages and mac-1 and PD-L1 in lupus-prone NZM2328 mice. J Immunol (2017) 198:2589&#x2013;601. doi:&#xa0;10.4049/jimmunol.1601565</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1601565</ArticleId><ArticleId IdType="pmc">PMC5360484</ArticleId><ArticleId IdType="pubmed">28219886</ArticleId></ArticleIdList></Reference><Reference><Citation>Sung S-SJ, Fu SM. Interactions among glomerulus infiltrating macrophages and intrinsic cells via cytokines in chronic lupus glomerulonephritis. J Autoimmun (2020) 106:102331. doi:&#xa0;10.1016/j.jaut.2019.102331</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102331</ArticleId><ArticleId IdType="pmc">PMC6930355</ArticleId><ArticleId IdType="pubmed">31495649</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriakose J, Redecke V, Guy C, Zhou J, Wu R, Ippagunta SK, et al. . Patrolling monocytes promote the pathogenesis of early lupus-like glomerulonephritis. J Clin Invest (2019) 129:2251&#x2013;65. doi:&#xa0;10.1172/JCI125116</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI125116</ArticleId><ArticleId IdType="pmc">PMC6546471</ArticleId><ArticleId IdType="pubmed">31033479</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiffer L, Bethunaickan R, Ramanujam M, Huang W, Schiffer M, Tao H, et al. . Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis. J Immunol (2008) 180:1938&#x2013;47. doi:&#xa0;10.4049/jimmunol.180.3.1938</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.180.3.1938</ArticleId><ArticleId IdType="pmc">PMC2587994</ArticleId><ArticleId IdType="pubmed">18209092</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma R, Jiang W, Li Z, Sun Y, Wei Z. Intrarenal macrophage infiltration induced by T cells is associated with podocyte injury in lupus nephritis patients. Lupus (2016) 25:1577&#x2013;86. doi:&#xa0;10.1177/0961203316646861</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316646861</ArticleId><ArticleId IdType="pubmed">27147620</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakhi H, Moktefi A, Bouachi K, Audard V, H&#xe9;nique C, Remy P, et al. . Podocyte injury in lupus nephritis. J Clin Med (2019) 8. doi:&#xa0;10.3390/jcm8091340</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm8091340</ArticleId><ArticleId IdType="pmc">PMC6780135</ArticleId><ArticleId IdType="pubmed">31470591</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Guo H, Miao X, Xu J, Yang R, Zhao L, et al. . Nestin protects podocyte from injury in lupus nephritis by mitophagy and oxidative stress. Cell Death Dis (2020) 11:319. doi:&#xa0;10.1038/s41419-020-2547-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-2547-4</ArticleId><ArticleId IdType="pmc">PMC7200703</ArticleId><ArticleId IdType="pubmed">32371936</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng W, Ren Y, Feng X, Yao G, Chen W, Sun Y, et al. . Hypoxia inducible factor-1 alpha promotes mesangial cell proliferation in lupus nephritis. Am J Nephrol (2014) 40:507&#x2013;15. doi:&#xa0;10.1159/000369564</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000369564</ArticleId><ArticleId IdType="pubmed">25531641</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen PM, Wilson PC, Shyer JA, Veselits M, Steach HR, Cui C, et al. . Kidney tissue hypoxia dictates T cell&#x2013;mediated injury in murine lupus nephritis. Sci Transl Med (2020) 12. doi:&#xa0;10.1126/scitranslmed.aay1620</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aay1620</ArticleId><ArticleId IdType="pmc">PMC8055156</ArticleId><ArticleId IdType="pubmed">32269165</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? towards the unifying theme of chronic hypoxia. Kidney Int Suppl (2000) 75:S22&#x2013;6. doi: 10.1046/j.1523-1755.57.s75.12.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1523-1755.57.s75.12.x</ArticleId><ArticleId IdType="pubmed">10828757</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortner KA, Blanco LP, Buskiewicz I, Huang N, Gibson PC, Cook DL, et al. . Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL- lpr mice. Lupus Sci Med (2020) 7. doi:&#xa0;10.1136/lupus-2020-000387</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2020-000387</ArticleId><ArticleId IdType="pmc">PMC7199895</ArticleId><ArticleId IdType="pubmed">32343673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S, Healy H, Kassianos AJ. The emerging role of renal tubular epithelial cells in the immunological pathophysiology of lupus nephritis. Front Immunol (2020) 11:578952. doi:&#xa0;10.3389/fimmu.2020.578952</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.578952</ArticleId><ArticleId IdType="pmc">PMC7538705</ArticleId><ArticleId IdType="pubmed">33072122</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonventre JV. Kidney injury molecule-1 (KIM-1): A urinary biomarker and much more. Nephrol Dial Transplant (2009) 24:3265&#x2013;8. doi:&#xa0;10.1093/ndt/gfp010</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ndt/gfp010</ArticleId><ArticleId IdType="pubmed">19318357</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, Vaidya VS, Brown RP, Zhang J, Rosenzweig BA, Thompson KL, et al. . Comparison of kidney injury molecule-1 and other nephrotoxicity biomarkers in urine and kidney following acute exposure to gentamicin, mercury, and chromium. Toxicol Sci (2008) 101:159&#x2013;70. doi:&#xa0;10.1093/toxsci/kfm260</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfm260</ArticleId><ArticleId IdType="pmc">PMC2744478</ArticleId><ArticleId IdType="pubmed">17934191</ArticleId></ArticleIdList></Reference><Reference><Citation>Castillo-Rodriguez E, Fernandez-Prado R, Martin-Cleary C, Pizarro-S&#xe1;nchez MS, Sanchez-Nin&#xf5; MD, Sanz AB, et al. . Kidney injury marker 1 and neutrophil gelatinase-associated lipocalin in chronic kidney disease. Nephron (2017) 136:263&#x2013;7. doi:&#xa0;10.1159/000447649</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000447649</ArticleId><ArticleId IdType="pubmed">27771693</ArticleId></ArticleIdList></Reference><Reference><Citation>Moschen AR, Adolph TE, Gerner RR, Wieser V, Tilg H. Lipocalin-2: A master mediator of intestinal and metabolic inflammation. Trends Endocrinol Metab (2017) 28:388&#x2013;97. doi:&#xa0;10.1016/j.tem.2017.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2017.01.003</ArticleId><ArticleId IdType="pubmed">28214071</ArticleId></ArticleIdList></Reference><Reference><Citation>Moulton VR. Sex hormones in acquired immunity and autoimmune disease. Front Immunol (2018) 9:2279. doi:&#xa0;10.3389/fimmu.2018.02279</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02279</ArticleId><ArticleId IdType="pmc">PMC6180207</ArticleId><ArticleId IdType="pubmed">30337927</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartzman-Morris J, Putterman C. Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol (2012) 2012:604892. doi:&#xa0;10.1155/2012/604892</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/604892</ArticleId><ArticleId IdType="pmc">PMC3368358</ArticleId><ArticleId IdType="pubmed">22690240</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansar Ahmed S, Penhale WJ, Talal N. Sex hormones, immune responses, and autoimmune diseases. mechanisms of sex hormone action. Am J Pathol (1985) 121:531&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1887926</ArticleId><ArticleId IdType="pubmed">3907369</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M, Wilder RL. Different roles for androgens and estrogens in the susceptibility to autoimmune rheumatic diseases. Rheum Dis Clin North Am (2000) 26:825&#x2013;39. doi:&#xa0;10.1016/s0889-857x(05)70171-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0889-857x(05)70171-x</ArticleId><ArticleId IdType="pubmed">11084946</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim G-J, Kis LL, Warner M, Gustafsson J-&#xc5;. Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene. Proc Natl Acad Sci (2004) 101:1720&#x2013;4. doi:&#xa0;10.1073/pnas.0307915100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0307915100</ArticleId><ArticleId IdType="pmc">PMC341834</ArticleId><ArticleId IdType="pubmed">14745006</ArticleId></ArticleIdList></Reference><Reference><Citation>Rider V, Jones SR, Evans M, Abdou NI. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol (2000) 95:124&#x2013;34. doi:&#xa0;10.1006/clim.2000.4844</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/clim.2000.4844</ArticleId><ArticleId IdType="pubmed">10779406</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang TJ, Nguyen P, Papadimitriou JC, Via CS. Increased severity of murine lupus in female mice is due to enhanced expansion of pathogenic T cells. J Immunol (2003) 171:5795&#x2013;801. doi:&#xa0;10.4049/jimmunol.171.11.5795</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.171.11.5795</ArticleId><ArticleId IdType="pubmed">14634088</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham JH, Yoachim SD, Gould KA. Estrogen receptor alpha signaling is responsible for the female sex bias in the loss of tolerance and immune cell activation induced by the lupus susceptibility locus Sle1b. Front Immunol (2020) 11:582214. doi:&#xa0;10.3389/fimmu.2020.582214</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.582214</ArticleId><ArticleId IdType="pmc">PMC7683613</ArticleId><ArticleId IdType="pubmed">33240270</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci (2002) 966:131&#x2013;42. doi:&#xa0;10.1111/j.1749-6632.2002.tb04210.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2002.tb04210.x</ArticleId><ArticleId IdType="pubmed">12114267</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubbels Bupp MR, Jorgensen TN. Androgen-induced immunosuppression. Front Immunol (2018) 9:794. doi:&#xa0;10.3389/fimmu.2018.00794</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00794</ArticleId><ArticleId IdType="pmc">PMC5932344</ArticleId><ArticleId IdType="pubmed">29755457</ArticleId></ArticleIdList></Reference><Reference><Citation>Aitman TJ, Dong R, Vyse TJ, Norsworthy PJ, Johnson MD, Smith J, et al. . Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature (2006) 439:851&#x2013;5. doi:&#xa0;10.1038/nature04489</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature04489</ArticleId><ArticleId IdType="pubmed">16482158</ArticleId></ArticleIdList></Reference><Reference><Citation>Stratigou V, Doyle AF, Carlucci F, Stephens L, Foschi V, Castelli M, et al. . Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity. Rheumatol (United Kingdom) (2017) 56:1206&#x2013;16. doi:&#xa0;10.1093/rheumatology/kex078</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kex078</ArticleId><ArticleId IdType="pmc">PMC5850773</ArticleId><ArticleId IdType="pubmed">28387859</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou D, Tan RJ, Fu H, Liu Y. Wnt/&#x3b2;-catenin signaling in kidney injury and repair: A double-edged sword. Lab Investig (2016) 96:156&#x2013;67. doi:&#xa0;10.1038/labinvest.2015.153</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2015.153</ArticleId><ArticleId IdType="pmc">PMC4731262</ArticleId><ArticleId IdType="pubmed">26692289</ArticleId></ArticleIdList></Reference><Reference><Citation>Weening JJ, D&#x2019;Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. . The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol (2004) 15:241&#x2013;50. doi:&#xa0;10.1097/01.ASN.0000108969.21691.5D</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.ASN.0000108969.21691.5D</ArticleId><ArticleId IdType="pubmed">14747370</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega LM, Schultz DR, Lenz O, Pardo V, Contreras GN. Lupus nephritis: Pathologic features, epidemiology and a guide to therapeutic decisions. Lupus (2010) 19:557&#x2013;74. doi:&#xa0;10.1177/0961203309358187</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309358187</ArticleId><ArticleId IdType="pubmed">20089610</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>